Hebei Changshan Biochemical Pharmaceutical Co Ltd
300255
Company Profile
Business description
Hebei Changshan Biochemical Pharmaceutical Co Ltd is a biotech high-tech enterprise. It is mainly engaged in the research, development, production, and sale of heparin series products. Some of the company's products are Reserpine sodium, Hyaluronic acid, Heparinoid, Heparin sodium, Tinzaparin sodium, Aspirin enteric-coated tablets, and Yihaitang.
Contact
North of Yinchuan Street
Zhengding New District, Hebei
Shijiazhuang050800
CHNT: +86 31189190198
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
1,254
Stocks News & Analysis
stocks
3 Warren Buffett stocks to avoid today
These are the most overvalued stocks in Berkshire Hathaway’s portfolio.
stocks
Should you invest in small caps?
With small capitalisation stocks gaining momentum, there are important considerations to determine whether they are right for your portfolio.
stocks
Strong second half anticipated for ASX mining play
A more focused business model should benefit the company.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,079.20 | 17.70 | 0.20% |
CAC 40 | 7,870.68 | 75.26 | 0.97% |
DAX 40 | 23,739.47 | 204.64 | 0.87% |
Dow JONES (US) | 46,247.29 | 299.97 | 0.65% |
FTSE 100 | 9,284.83 | 70.85 | 0.77% |
HKSE | 26,128.20 | 356.48 | -1.35% |
NASDAQ | 22,484.07 | 99.37 | 0.44% |
Nikkei 225 | 45,354.99 | 399.94 | -0.87% |
NZX 50 Index | 13,111.73 | 42.06 | -0.32% |
S&P 500 | 6,643.70 | 38.98 | 0.59% |
S&P/ASX 200 | 8,787.70 | 13.20 | 0.15% |
SSE Composite Index | 3,828.11 | 25.20 | -0.65% |